Federal Register / Vol. 62, No. 245 / Monday, December 22, 1997 / Notices 66871

Dated: December 15, 1997.

John M. Eisenberg,

Administrator.

[FR Doc. 97–33253 Filed 12–19–97; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Health Care Policy and

Research

Notice of Assessment of Medical

Technology

The Agency for Health Care Policy

and Research (AHCPR), through the

Center for Practice and Technology

Assessment (CPTA), announces that it is

initiating an assessment of the

effectiveness of Prostate-specific antigen

(PSA) testing in patients with benign

prostatic hyperplasia (BPH).

The AHCPR is requesting information

on the utility, and costs associated with

the use of PSA testing and the specific

indications for which this testing is

appropriate. The AHCPR also requests

information on patient selection criteria.

The assessment consists of a synthesis

of information found in published

literature and obtained from appropriate

organizations in the private sector,

Public Health Service (PHS) agencies

and others in the Federal Government.

AHCPR assessments are conducted in

accordance with sections 904(b) and (d)

of the PHS Act (42 U.S.C. 299a–2(b) and

(d)). The assessment is based on the

most current knowledge concerning the

clinical effectiveness and appropriate

uses of the technology being evaluated.

The information being sought by this

notice is a review and evaluation of

past, current, and planned research

related to this technology, as well as a

bibliography of published, controlled

clinical trials and other well-designed

clinical studies. Information related to

the characteristics of the patient

population most likely to benefit from

PSA testing as well as information on

the clinical acceptability, effectiveness,

and the extent of use of this technology,

is also being sought. Following

completion of the assessment, a

recommendation will be formulated to

assist the Health Care Financing

Administration (HCFA) in establishing

Medicare coverage policy.

The AHCPR is interested in receiving

information which would help in the

evaluation or review of the technology

as described above. To enable the

interested scientific community to

evaluate the information and analysis

included in the assessment, AHCPR will

discuss in the assessment only those

data and analyses for which a source(s)

can be cited. Respondents are therefore

encouraged to include with their

submissions a written consent

permitting AHCPR ‘‘to cite and make

public the sources of the data and the

comments provided’’. Otherwise, in

accordance with the confidentiality

statute governing information collected

by AHCPR, 42 U.S.C. 299a–1(c), no

information received will be published

or disclosed which could identify an

entity or individual supplying the

information or any individual or entity

described in the information. In

addition, clearly market proprietary

information may be kept confidential in

accordance with the Freedom of

Information Act, 5 U.S.C. § 552(b)(4).

Any person or group wishing to

provide AHCPR with information

relevant to this assessment should do so

in writing no later than March 23, 1998

to: Douglas B. Kamerow, M.D., M.P.H.,

Director, Center for Practice and

Technology Assessment, Agency for

Health Care Policy and Research, 6000

Executive Boulevard, Suite 310,

Rockville, MD 20852, Phone: (301) 594–

4015.

Dated: December 15, 1997.

John M. Eisenberg,

Administrator.

[FR Doc. 97–33252 Filed 12–19–97; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Number 816]

Individual Grants for Extramural Injury

Research for Primary Prevention of

Unintentional Injuries, Acute Care,

Disability Prevention, and

Biomechanics; Notice of Availability of

Funds for Fiscal Year 1998

Introduction

The Centers for Disease Control and

Prevention (CDC) announces that

applications are being accepted for

Injury Prevention and Control Research

Grants for fiscal year (FY) 1998.

CDC is committed to achieving the

health promotion and disease

prevention objectives of Healthy People

2000, a national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority area of

Unintentional Injuries. (To order a copy

of Healthy People 2000, see the Section

Where to Obtain Additional

Information.)

Authority

This program is authorized under

Sections 301, 391–394 of the Public

Health Service Act (42 USC 241, 280b–

280b–3), as amended. Program

regulations are set forth in Title 42 CFR

Part 52.

Smoke-Free Workplace

CDC strongly encourages all grant and

cooperative agreement recipients to

provide a smoke-free workplace and to

promote the non-use of all tobacco

products, and Public Law 103–227, the

Pro-Children Act of 1994, prohibits

smoking in certain facilities that receive

Federal funds in which education,

library, day care, health care, and early

childhood development services are

provided to children.

Eligible Applicants

Eligible applicants include all

nonprofit and for-profit organizations.

Thus State and local health departments

and State and local governmental

agencies, universities, colleges, research

institutions, and other public and

private organizations, including small,

minority and/or woman-owned

businesses are eligible for these research

grants. Current holders of CDC injury

control research projects are eligible to

apply.

Note: An organization described in section

501(c)(4) of the Internal Revenue Code of

1986 which engages in lobbying activities

shall not be eligible to receive Federal funds

constituting an award, a grant, contract, loan,

or any other form.

Availability of Funds

Approximately $2.7 million is

available for FY 1998 injury research

grants that include funding for projects

that address primary prevention of

unintentional injuries (home and

leisure, and motor vehicle relatedinjuries), acute care, the prevention of

secondary conditions in persons with

disabilities, and biomechanics.

Approximately $1,800,000 is available

to support 6–8 projects that address

primary prevention of unintentional

injuries (home and leisure, and motor

vehicle related-injuries), acute care, and

the prevention of secondary conditions

in persons with disabilities. Awards

will be made for a 12-month budget

period within a project period not to

exceed three years. The maximum

funding level per year will not exceed

$300,000 (including both direct and

indirect costs). Applications that exceed

the funding cap of $300,000 will be

excluded from the competition and

returned to the applicant.

Approximately $900,000 is available

to support 3–5 projects that address